Create Alert
Watchlist

Divi's Laboratories

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹1,59,536Cr
ROE14.64%
P/E Ratio(TTM)69.18
EPS(TTM)86.87
P/B Ratio10.66
Dividend Yield0.50%
Industry P/E34.72
Book Value563.87
Debt to Equity0.00
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Divi's Labs

Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to generic business, the Company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management. The Company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.;
Parent OrganisationDivi's Laboratories Limited
Managing DirectorDr. Murali Divi
NSE SymbolDIVISLAB

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
51.89%
Foreign Institutions
19.74%
Mutual Funds
13.31%
Retail And Others
9.32%
Other Domestic Institutions
5.74%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Neuland Laboratories
NA
(0.00%)
105.31
Jubilant Pharmova
NA
(0.00%)
37.03
Acutaas Chemicals
NA
(0.00%)
63.39
Aarti Drugs
NA
(0.00%)
22.94